Related Experiment Video

Updated: May 2, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

8.1K

Influence of bottle-feeding on serum bisphenol a levels in infants

Young-Jun Rhie1, Hyo-Kyoung Nam1, Yeon Joung Oh2

  • 1Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.

Journal of Korean Medical Science
|February 20, 2014
PubMed

Insights

Bottle-feeding significantly increases infant exposure to Bisphenol A (BPA), an endocrine disrupting chemical found in plastics. Health policies are needed to reduce this widespread BPA exposure in babies.

Area of Science:

  • Environmental Health
  • Pediatric Health
  • Toxicology

Background:

  • Endocrine disrupting chemicals (EDCs) pose risks, especially during development.
  • Bisphenol A (BPA) is a prevalent EDC found in common plastic products.
  • Infant exposure to BPA is a growing public health concern.

Purpose of the Study:

  • To investigate infant exposure to Bisphenol A (BPA).
  • To determine the effect of bottle-feeding on serum BPA levels in infants.
  • To assess potential correlations between BPA levels and infant demographics.

Main Methods:

  • Serum BPA levels were measured in 60 healthy infants aged 6-15 months using competitive ELISA.
  • Infants were categorized into bottle-fed and breast-fed groups.
  • Statistical analysis compared BPA levels between groups and correlated them with age, weight, and gestational age.

Main Results:

  • BPA was detected in all infant serum samples.
  • Bottle-fed infants exhibited significantly higher serum BPA levels (96.58±102.36 pg/mL) compared to breast-fed infants (45.53±34.05 pg/mL).
  • No significant differences in BPA levels were observed between genders, nor correlations with age, weight, or gestational age.

Conclusions:

  • Bottle-feeding is associated with increased infant exposure to BPA.
  • Urgent establishment of health policies is recommended to mitigate BPA exposure in infants.
  • Reducing BPA in products used by infants is crucial for protecting developmental health.

Keywords:
Baby BottleBisphenol ABottle-FeedingEndocrine Disrupting ChemicalInfant

More Related Videos

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays08:28

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays

Published on: April 26, 2018

8.8K
Sampling, Identification and Characterization of Microplastics Release from Polypropylene Baby Feeding Bottle during Daily Use05:48

Sampling, Identification and Characterization of Microplastics Release from Polypropylene Baby Feeding Bottle during Daily Use

Published on: July 24, 2021

5.2K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
65
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K